Back

Factors associated with NT-proBNP reduction in acute heart failure: a secondary analysis of the PREMIER trial

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Enhanced aspects of clinical care Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Yosuke Nabeshima

Saga University Hospital, Saga (Japan)

6 More presentations in this session

Presentation thumbnail
Long term follow-up of autosomal recessive atrial dilated cardiomyopathy associated with mutation of natriuretic peptide precursor A
Doctor M. Iseppi (Trento, IT)
Abstract
Presentation thumbnail
Operational characteristics of a clinical algorithm to optimize the detection of undiagnosed heart failure in primary care: insights from a prospective, multicenter study
Professor S. Stewart (Fremantle, AU)
Abstract
Presentation thumbnail
Artificial intelligence-enabled electrocardiography for identifying heart failure in patients with dyspnea in the emergency department
Associate Professor J. Park (Seongnam, KR)
Abstract
Presentation thumbnail
AI-enabled ECG imaging for the detection of cardiac amyloidosis across amyloidosis subtypes
Miss A. Achten (Maastricht, NL)
Abstract
Presentation thumbnail
Circulating dipeptidyl peptidase 3 levels in acute heart failure: insights from the PUSH-AHF trial
Mr S. Legtenberg (Groningen, NL)
Abstract

Access the full session

Session thumbnail
Enhanced aspects of clinical care

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources